Cannassure Therapeutics Ltd (CSURE.M)
Delisted
TASE TASE Primary TASE 15.38M Market Cap
- P/E Ratio
- Div Yield
- Volume
- Eps
ILA
Previous Close Day Range
0 0
Year Range
0 0
Want to track CSURE.M and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
This company has been delisted from its primary exchange and is no longer publicly traded.
As a result, real-time price data, dividend updates, and corporate disclosures may no longer be available.
CSURE.M Chart
Cannassure Therapeutics Ltd (CSURE.M) FAQ
What does "Delisted" mean?
Cannassure Therapeutics Ltd has been removed from the exchange and is no longer publicly traded.
What was the last recorded dividend?
No dividend payments were recorded prior to delisting.
How long did the company pay dividends?
The company did not have a dividend payment history.
Were there any stock splits?
No stock splits were recorded prior to delisting.
What was the last known trading price?
Final trading price data is not available.
Cannassure Therapeutics Ltd Profile
| - Industry | - Sector | H.E Evyatar Cohen CEO | TASE Exchange | - ISIN |
| Israel Country | 2 Employees | - Last Dividend | 17 Mar 2024 Last Split | - IPO Date |
Overview
Cannassure Therapeutics Ltd is an Israel-based company dedicated to the cultivation and production of medical cannabis. Founded in 2016 and headquartered in Ashdod, Israel, it has positioned itself within the medical cannabis industry, focusing on the development of high-quality cannabis products for patients. Their operations embody the cultivation of cannabis plants under controlled conditions, ensuring that the products meet strict medical standards and cater to the needs of individuals seeking relief through medicinal cannabis.
Products and Services
- Medical Cannabis Oils - These oils are extracted from high-grade medical cannabis, designed for patients searching for an alternative form of medication. The precise extraction processes guarantee the preservation of beneficial cannabinoids and terpenes, providing a potent and effective remedy for various conditions.
- Indoor Inflorescences - Cultivated within the controlled environment of indoor facilities, these premium cannabis flowers are specifically grown to maintain consistent quality and cannabinoid profiles. Suitable for patients who require reliable strength and purity in their medicinal cannabis.
- Select Inflorescences - A curated selection of cannabis flowers, characterized by their exceptional quality and unique properties. These are tailored for connoisseurs and individuals with specific therapeutic needs, showcasing the best of what Cannassure has to offer.
- Value Inflorescences - These cannabis flowers offer an effective solution for patients seeking medicinal benefits at a more accessible price point. While they are more budget-friendly, they still adhere to Cannassure’s commitment to quality and efficacy.
- Cannavix - This product line may represent Cannassure’s proprietary or specialized formulations, indicating a focus on innovation within the therapeutic cannabis market. Although details are not specified, Cannavix likely encompasses products or technologies developed to enhance the patient experience with medical cannabis.
Contact Information
Address: 2 Hahadarim Street
Phone: 972 7 65313245
Website: https://cannassure.life
